The ability to alter proteins to refine control over binding affinity and specificity can create tailored therapeutics with reduced side effects, highly sensitive diagnostic tools, efficient ...
WiSA Technologies, Inc. (Nasdaq: WISA) today announced CES 2025 was highly successful with WiSA ® and Datavault ® brands demonstrating groundbreaking Web 3.0 technologies. Recognition from Forbes in ...